Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.76 billion. The enterprise value is $3.10 billion.
Important Dates
The last earnings date was Tuesday, October 29, 2024, after market close.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 36.35 million shares outstanding. The number of shares has decreased by -2.01% in one year.
| Current Share Class | 36.35M |
| Shares Outstanding | 36.35M |
| Shares Change (YoY) | -2.01% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 101.75% |
| Float | 36.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.18 |
| PS Ratio | 1.13 |
| Forward PS | 1.10 |
| PB Ratio | 7.84 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 60.93 |
| P/OCF Ratio | 15.69 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.14, with an EV/FCF ratio of 109.27.
| EV / Earnings | n/a |
| EV / Sales | 2.10 |
| EV / EBITDA | 9.14 |
| EV / EBIT | 13.31 |
| EV / FCF | 109.27 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 7.26.
| Current Ratio | 1.76 |
| Quick Ratio | 0.92 |
| Debt / Equity | 7.26 |
| Debt / EBITDA | 4.30 |
| Debt / FCF | 54.86 |
| Interest Coverage | 2.43 |
Financial Efficiency
Return on equity (ROE) is -120.81% and return on invested capital (ROIC) is 7.22%.
| Return on Equity (ROE) | -120.81% |
| Return on Assets (ROA) | 5.85% |
| Return on Capital (ROIC) | 7.22% |
| Revenue Per Employee | $870,176 |
| Profits Per Employee | -$331,588 |
| Employee Count | 1,700 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.23 |
Taxes
| Income Tax | -134.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.17% in the last 52 weeks. The beta is 1.61, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +15.17% |
| 50-Day Moving Average | 39.10 |
| 200-Day Moving Average | 43.48 |
| Relative Strength Index (RSI) | 65.20 |
| Average Volume (20 Days) | 402,942 |
Short Selling Information
The latest short interest is 1.07 million, so 2.94% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 2.94% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.48 billion and -$563.70 million in losses. Loss per share was -$15.54.
| Revenue | 1.48B |
| Gross Profit | 432.10M |
| Operating Income | 233.10M |
| Pretax Income | -528.40M |
| Net Income | -563.70M |
| EBITDA | 339.40M |
| EBIT | 233.10M |
| Loss Per Share | -$15.54 |
Full Income StatementBalance Sheet
The company has $135.50 million in cash and $1.56 billion in debt, giving a net cash position of -$1.42 billion or -$39.13 per share.
| Cash & Cash Equivalents | 135.50M |
| Total Debt | 1.56B |
| Net Cash | -1.42B |
| Net Cash Per Share | -$39.13 |
| Equity (Book Value) | 214.50M |
| Book Value Per Share | 5.90 |
| Working Capital | 276.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $110.30 million and capital expenditures -$81.90 million, giving a free cash flow of $28.40 million.
| Operating Cash Flow | 110.30M |
| Capital Expenditures | -81.90M |
| Free Cash Flow | 28.40M |
| FCF Per Share | $0.78 |
Full Cash Flow StatementMargins
Gross margin is 29.21%, with operating and profit margins of 15.76% and -38.11%.
| Gross Margin | 29.21% |
| Operating Margin | 15.76% |
| Pretax Margin | -47.21% |
| Profit Margin | -38.11% |
| EBITDA Margin | 22.94% |
| EBIT Margin | 15.76% |
| FCF Margin | 4.63% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.01% |
| Shareholder Yield | 2.01% |
| Earnings Yield | -32.58% |
| FCF Yield | 1.64% |
Dividend DetailsAnalyst Forecast
The average price target for Ingevity is $51.00, which is 5.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $51.00 |
| Price Target Difference | 5.19% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 1.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 4 |